See more : FSD Pharma Inc. (HUGE) Income Statement Analysis – Financial Results
Complete financial analysis of Berli Jucker Public Company Limited (BJC.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Berli Jucker Public Company Limited, a leading company in the Conglomerates industry within the Industrials sector.
- Hankook Steel Co., Ltd. (025890.KS) Income Statement Analysis – Financial Results
- PT Berkah Beton Sadaya Tbk (BHBSY) Income Statement Analysis – Financial Results
- Continental Chemicals Limited (CONTCHM.BO) Income Statement Analysis – Financial Results
- LZG International, Inc. (LZGI) Income Statement Analysis – Financial Results
- Global Ports Holding Plc (GPH.L) Income Statement Analysis – Financial Results
Berli Jucker Public Company Limited (BJC.BK)
About Berli Jucker Public Company Limited
Berli Jucker Public Company Limited manufactures, distributes, and services in the areas of packaging, consumer, healthcare and technical, modern retail supply chain, and other group businesses in Thailand. It designs, manufactures, markets, and distributes glass and plastic packaging products, and aluminum cans. The company is involved in the distribution of personal care products, including Cellox facial tissues and toilet papers, Zilk toilet papers, Maxmo multi-purpose papers, Tasto potato chips, Dozo rice crackers, Party and Campus extruded snacks, Parrot soaps, and Dermapon baby soaps, as well as provides logistics management services, such as warehouse, transportation, customs brokerage, and freight forwarding representative services. In addition, it offers food products comprises snacks, beverages, packaged fruits, and dairy and yogurt products; and non-food products, which includes personal care, household products, stationery and office equipment, and others. Further, the company imports and distributes medicines, medical supplies, cosmeceuticals, pharmaceuticals, food supplements, and health products; medicines for treatment of various diseases such as kidney, hematology, cardiovascular, endocrine system, genitourinary system, skeleton, infection, oncology and tumors, pediatric medicines, and beauty products. It also offers medical devices, such as computed radiography systems, ultrasound systems, digital mammography systems, X-ray systems, 3D medical image processing systems, and laboratory information systems. Additionally, the company engages in bakery, food and nutraceutical, and cosmetic ingredients; industrial chemicals and refrigerants; e-commerce business; consultancy, design, installation, and the after-sales services for cranes and solar rooftop system; and weighing control system. The company was founded in 1882 and is headquartered in Bangkok, Thailand. Berli Jucker Public Company Limited is a subsidiary of TCC Corporation Company Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 154.67B | 150.34B | 138.46B | 144.73B | 158.01B | 156.14B | 149.16B | 125.33B | 42.89B | 43.42B | 42.23B | 37.43B | 31.23B | 26.36B | 23.07B | 22.45B | 19.40B | 15.56B | 15.16B | 14.97B | 13.75B | 12.07B | 11.47B | 10.56B |
| Cost of Revenue | 124.63B | 122.71B | 112.45B | 117.25B | 127.12B | 126.17B | 120.71B | 102.77B | 33.07B | 33.64B | 32.13B | 28.40B | 23.45B | 18.94B | 17.20B | 17.37B | 14.56B | 11.34B | 11.06B | 10.41B | 9.50B | 8.39B | 8.23B | 7.77B |
| Gross Profit | 30.04B | 27.63B | 26.02B | 27.48B | 30.89B | 29.97B | 28.45B | 22.56B | 9.82B | 9.78B | 10.10B | 9.03B | 7.78B | 7.42B | 5.87B | 5.08B | 4.84B | 4.22B | 4.11B | 4.56B | 4.25B | 3.68B | 3.24B | 2.79B |
| Gross Profit Ratio | 19.42% | 18.38% | 18.79% | 18.99% | 19.55% | 19.19% | 19.07% | 18.00% | 22.90% | 22.52% | 23.91% | 24.12% | 24.91% | 28.15% | 25.46% | 22.62% | 24.95% | 27.11% | 27.08% | 30.49% | 30.90% | 30.48% | 28.23% | 26.43% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.07B | 4.69B | 4.24B | 4.83B | 5.28B | 5.03B | 5.11B | 4.50B | 2.42B | 2.61B | 2.55B | 2.08B | 1.63B | 1.43B | 1.01B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 26.57B | 25.20B | 23.38B | 24.85B | 27.94B | 27.23B | 25.57B | 19.03B | 4.76B | 5.01B | 4.47B | 4.03B | 3.20B | 2.96B | 2.97B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 31.65B | 29.89B | 27.62B | 29.69B | 33.22B | 32.26B | 30.69B | 23.53B | 7.18B | 7.63B | 7.02B | 6.12B | 4.83B | 4.39B | 3.98B | 3.32B | 2.91B | 2.85B | 2.61B | 2.73B | 2.39B | 2.26B | 2.15B | 1.90B |
| Other Expenses | -13.36B | 13.18B | 11.39B | 12.80B | 15.93B | 15.73B | 14.85B | 11.16B | 545.78M | 683.50M | 489.77M | 514.44M | 0.00 | 0.00 | 0.00 | 0.00 | 3.13M | 0.00 | 0.00 | 0.00 | 7.39M | 344.24M | 546.10M | -92.25M |
| Operating Expenses | 20.64B | 29.89B | 27.62B | 29.69B | 33.22B | 32.26B | 30.69B | 23.53B | 6.61B | 7.63B | 7.02B | 6.12B | 4.83B | 4.39B | 3.98B | 3.32B | 2.92B | 2.85B | 2.61B | 2.73B | 2.40B | 2.60B | 2.70B | 1.81B |
| Cost & Expenses | 145.27B | 152.60B | 140.06B | 146.94B | 160.34B | 158.44B | 151.39B | 126.30B | 39.68B | 41.27B | 39.15B | 34.52B | 28.28B | 23.33B | 21.18B | 20.69B | 17.47B | 14.20B | 13.67B | 13.14B | 11.90B | 10.99B | 10.93B | 9.58B |
| Interest Income | 42.80M | 29.46M | 23.97M | 71.21M | 63.55M | 28.39M | 18.10M | 37.75M | 21.45M | 17.57M | 15.27M | 22.70M | 21.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -108.37M | -155.57M |
| Interest Expense | 5.34B | 4.75B | 5.09B | 5.27B | 4.97B | 4.72B | 4.53B | 5.20B | 492.51M | 612.23M | 575.18M | 502.88M | 366.04M | 227.01M | 222.16M | 229.52M | 146.96M | 153.96M | 100.46M | 64.33M | 76.89M | 25.75M | 108.37M | 155.57M |
| Depreciation & Amortization | 8.98B | 9.01B | 9.07B | 7.50B | 5.16B | 5.09B | 4.98B | 4.31B | 2.14B | 2.27B | 2.02B | 1.75B | 1.78B | 1.42B | 1.34B | -156.56M | -1.07M | -1.08M | -1.04M | -699.29K | 519.30M | 0.00 | 158.06M | 175.60M |
| EBITDA | 20.54B | 20.01B | 19.12B | 18.27B | 18.86B | 18.85B | 17.72B | 14.85B | 6.01B | 5.00B | 5.67B | 5.35B | 4.78B | 4.50B | 3.29B | 3.03B | 1.79B | 1.36B | 1.49B | 1.82B | 2.37B | 1.08B | 371.08M | 843.93M |
| EBITDA Ratio | 13.28% | 13.27% | 13.48% | 13.41% | 13.41% | 13.39% | 13.44% | 12.56% | 14.00% | 11.98% | 13.43% | 14.07% | 15.31% | 17.09% | 14.28% | 7.13% | 9.24% | 8.77% | 9.81% | 12.15% | 17.26% | 8.92% | 4.18% | 8.00% |
| Operating Income | 11.75B | 11.00B | 10.08B | 10.51B | 13.54B | 13.36B | 12.77B | 10.41B | 3.86B | 2.93B | 3.65B | 3.51B | 3.00B | 3.09B | 1.96B | 1.76B | 1.93B | 1.37B | 1.50B | 1.83B | 1.85B | 1.08B | 321.38M | 668.33M |
| Operating Income Ratio | 7.60% | 7.32% | 7.28% | 7.26% | 8.57% | 8.55% | 8.56% | 8.30% | 9.01% | 6.74% | 8.64% | 9.39% | 9.60% | 11.72% | 8.48% | 7.83% | 9.92% | 8.79% | 9.87% | 12.25% | 13.49% | 8.92% | 2.80% | 6.33% |
| Total Other Income/Expenses | -5.54B | -4.77B | -5.31B | -5.43B | -5.10B | -4.43B | -4.53B | -5.07B | -11.73M | -482.59M | -467.17M | -414.58M | 153.49M | -228.05M | -158.43M | -194.11M | -279.07M | 50.68M | -109.46M | -78.41M | -76.89M | -25.75M | 27.60M | 20.03M |
| Income Before Tax | 6.21B | 6.24B | 4.79B | 5.34B | 8.59B | 8.93B | 8.23B | 6.28B | 3.85B | 2.34B | 3.18B | 3.10B | 3.11B | 2.86B | 1.74B | 1.37B | 1.65B | 1.21B | 1.39B | 1.76B | 1.78B | 1.05B | 371.08M | 688.36M |
| Income Before Tax Ratio | 4.02% | 4.15% | 3.46% | 3.69% | 5.44% | 5.72% | 5.52% | 5.01% | 8.98% | 5.38% | 7.53% | 8.28% | 9.95% | 10.86% | 7.52% | 6.11% | 8.49% | 7.78% | 9.15% | 11.72% | 12.93% | 8.71% | 3.23% | 6.52% |
| Income Tax Expense | 502.95M | 435.42M | 508.32M | 787.11M | 820.34M | 1.65B | 2.26B | 1.25B | 400.07M | 480.52M | 566.58M | 604.61M | 692.67M | 668.05M | 415.22M | 294.60M | 391.37M | 343.05M | 431.09M | 568.11M | 565.50M | 371.79M | 48.43M | 145.29M |
| Net Income | 4.79B | 5.01B | 3.58B | 4.00B | 7.28B | 6.65B | 5.21B | 4.00B | 2.79B | 1.68B | 2.43B | 2.41B | 2.18B | 1.91B | 1.26B | 1.23B | 1.25B | 867.54M | 956.03M | 1.19B | 1.19B | 679.08M | 300.57M | 535.25M |
| Net Income Ratio | 3.10% | 3.33% | 2.59% | 2.76% | 4.61% | 4.26% | 3.49% | 3.19% | 6.51% | 3.87% | 5.75% | 6.45% | 6.97% | 7.23% | 5.47% | 5.49% | 6.47% | 5.57% | 6.31% | 7.93% | 8.62% | 5.63% | 2.62% | 5.07% |
| EPS | 1.20 | 1.25 | 0.89 | 1.00 | 1.82 | 1.66 | 1.31 | 1.28 | 1.62 | 0.98 | 1.42 | 1.41 | 1.25 | 1.11 | 0.73 | 0.63 | 0.73 | 5.85 | 0.57 | 0.70 | 0.70 | 0.40 | 0.18 | 0.31 |
| EPS Diluted | 1.20 | 1.25 | 0.89 | 1.00 | 1.82 | 1.66 | 1.30 | 1.27 | 1.62 | 0.97 | 1.41 | 1.41 | 1.25 | 1.11 | 0.73 | 0.63 | 0.73 | 5.85 | 0.57 | 0.70 | 0.70 | 0.40 | 0.18 | 0.31 |
| Weighted Avg Shares Out | 4.01B | 4.01B | 4.01B | 4.01B | 4.00B | 4.00B | 3.99B | 2.59B | 1.72B | 1.71B | 1.71B | 1.71B | 1.71B | 1.71B | 1.71B | 1.71B | 1.71B | 169.13M | 1.69B | 1.69B | 1.69B | 1.69B | 1.71B | 1.71B |
| Weighted Avg Shares Out (Dil) | 4.01B | 4.01B | 4.01B | 4.01B | 4.01B | 4.00B | 4.00B | 2.60B | 1.72B | 1.72B | 1.72B | 1.71B | 1.71B | 1.71B | 1.71B | 1.71B | 1.71B | 169.13M | 1.69B | 1.69B | 1.69B | 1.69B | 1.71B | 1.71B |
Source: https://incomestatements.info
Category: Stock Reports